Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Pharma, Inc.

68.39
-3.9900-5.51%
Pre-market: 67.60-0.7900-1.16%04:00 EDT
Volume:3.99M
Turnover:274.93M
Market Cap:13.39B
PE:-19.16
High:72.41
Open:72.26
Low:66.96
Close:72.38
52wk High:93.42
52wk Low:48.78
Shares:195.81M
Float Shares:167.00M
Volume Ratio:1.80
T/O Rate:2.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5686
EPS(LYR):-3.7850
ROE:-1789.67%
ROA:-26.00%
PB:-5.32
PE(LYR):-18.07

Loading ...

Jun 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 27, 2026

Major Issues Report

Form 8-K - Current report
May 21, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 18, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 13, 2026

Major Issues Report

Form 8-K - Current report
May 08, 2026

Major Issues Report

Form 8-K - Current report
May 07, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2026

Major Issues Report

Form 8-K - Current report
Apr 16, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 31, 2026

Major Issues Report

Form 8-K - Current report
Mar 13, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 10, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 24, 2026

Major Issues Report

Form 8-K - Current report
Feb 19, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities